Abstract:In this paper, a free boundary model of tumor growth with drug application including the heterogeneity or different types of tumor cells (caused by mutations and different values of drug and nutrient concentrations inside the tumor) is studied. Heterogeneity is included in the model by a variable −1≤y≤1 . It is assumed that converting from mutation y1 to mutation y2 happens with probability P(y1,y2) . A Caputo time fractional‐order hyperbolic equation describes the evolution of tumor cells depending on y . It also includes two Caputo time fractional‐order parabolic equations describing the diffusions of nutrients (e.g., oxygen and glucose) and drug concentrations. Instead of integer‐order time derivatives, the fractional ones are considered. In this study, it is aimed to employ the least squares curve fitting method to fit the order of fractional derivatives, coefficient, and rates of the model. For this purpose, using the mathematical model, we have considered the boundary densities of the tumor cells of different types and near‐boundary concentrations of drug and nutrient as the functions of the unknown orders, coefficients and rates (unknown variables). Due to the complexity of the problem, we have obtained the functions numerically. For this, using a change of variable, we have changed the free boundary problem to a problem with fixed domain. Thus, Riemann–Liouville fractional‐order integrals are added to the problem. In the spatial domain, the problem is discretized using the collocation method. In the temporal domain, the fractional derivatives and integrals (with order α ) are approximated in mesh points (with step size t∗ ) applying a method with error O((t∗)2−α) . Then, the unknown variables are obtained by fitting the functions for unknown variables to the data. In order to obtain the variables, a quadratic objective function is considered. The discretized function is substituted into the objective function, then the objective function is minimized using the trust‐region reflective algorithm. Finally, some numerical examples are presented to verify the efficiency of the method. In the examples, we have added noises generated from Gaussian distributions to the data and the effects of noise on the fitted coefficients, and rates are illustrated using some figures and tables. The noisy data are also plotted to have a clear vision of the effects of noises on the data. It is shown that despite the noise, the prediction of the radius of the tumor is acceptable.

A Mathematical Modeling of Patient-Derived Lung Cancer Stem Cells withFractional-Order Derivative

Cancer Stem Cell, Niche and EGFR Decide Tumor Development and Treatment Response: A Bio-Computational Simulation Study.

An optimal solution of lung cancer mathematical model using generalized Bessel polynomials

Fractional calculus in mathematical oncology

Fractional derivative model for tumor cells and immune system competition

Mathematical analysis and numerical simulation for fractal-fractional cancer model

Stability analysis of fractional order breast cancer model in chemotherapy patients with cardiotoxicity by applying LADM

Learning parameter values of a fractional model of cancer employing boundary densities of tumor cells

On The Chaotic Nature Of A Caputo Fractional Mathematical Model Of Cancer And Its Crossover Behaviors

Fractional order cancer model infection in human with CD8+ T cells and anti-PD-L1 therapy: simulations and control strategy

Mathematical modeling and dynamic analysis for cancer resistance incorporating persister cells

Mathematical Modeling of Non-Small-Cell Lung Cancer Biology through the Experimental Data on Cell Composition and Growth of Patient-Derived Organoids

Optimal chemotherapy and immunotherapy schedules for a cancer-obesity model with Caputo time fractional derivative

Mathematical modeling of interactions between colon cancer and immune system with a deep learning algorithm

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Mathematical modeling and control of lung cancer with IL2 cytokine and anti-PD-L1 inhibitor effects for low immune individuals

Towards personalized computer simulations of breast cancer treatment

Modeling different strategies towards control of lung cancer: leveraging early detection and anti-cancer cell measures

Predicting Radiotherapy Patient Outcomes with Real-Time Clinical Data Using Mathematical Modelling

Hybrid fractional derivative for modeling and analysis of cancer treatment with virotherapy